In last trading session, Resmed Inc (NYSE:RMD) saw 0.89 million shares changing hands with its beta currently measuring 0.77. Company’s recent per share price level of $257.92 trading at $1.5 or 0.58% at ring of the bell on the day assigns it a market valuation of $37.82B. That closing price of RMD’s stock is at a discount of -1.99% from its 52-week high price of $263.05 and is indicating a premium of 23.84% from its 52-week low price of $196.43. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.72 million shares which gives us an average trading volume of 888.96K if we extend that period to 3-months.
For Resmed Inc (RMD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.86. Splitting up the data highlights that, out of 19 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 8 suggested the stock as a Hold whereas 10 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Resmed Inc (NYSE:RMD) trade information
Resmed Inc’s shares saw a change of 24.72% in year-to-date performance and have moved 1.38% in past 5-day. Resmed Inc (NYSE:RMD) showed a performance of 3.13% in past 30-days. Number of shares sold short was 9.93 million shares which calculate 11.58 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 265 to the stock, which implies a rise of 2.67% to its current value. Analysts have been projecting 240 as a low price target for the stock while placing it at a high target of 286. It follows that stock’s current price would jump 6.95% in reaching the projected high whereas dropping to the targeted low would mean a gain of 6.95% for stock’s current value.
Resmed Inc (RMD) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 19.83% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 23.10% while estimates for its earnings growth in next 5 years are of 14.83%.
RMD Dividends
Resmed Inc is more likely to be releasing its next quarterly report on 2025-Apr-23 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 0.82%, the share has a forward dividend of 2.12 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 0.83%.
Resmed Inc (NYSE:RMD)’s Major holders
Insiders are in possession of 0.66% of company’s total shares while institution are holding 65.45 percent of that, with stock having share float percentage of 65.89%. Investors also watch the number of corporate investors in a company very closely, which is 65.45% institutions for Resmed Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at RMD for having 17.9 million shares of worth $3.43 billion. And as of 2024-06-30, it was holding 12.1841 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 11.69 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.9583 of outstanding shares, having a total worth of $2.24 billion.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025, the former fund manager was holding 4.64 shares of worth $1.2 billion or 3.17% of the total outstanding shares. The later fund manager was in possession of 4.08 shares on Mar 31, 2025, making its stake of worth around $1.05 billion in the company or a holder of 2.78% of company’s stock.
